BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹4,102 Cr | ₹3,985 Cr | ₹2,588 Cr | ₹3,420 Cr | ₹2,254 Cr |
What is the latest Capital Work in Progress ratio of BIOCON ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹4,102 Cr |
| Mar2024 | ₹3,985 Cr |
| Mar2023 | ₹2,588 Cr |
| Mar2022 | ₹3,420 Cr |
| Mar2021 | ₹2,254 Cr |
How is Capital Work in Progress of BIOCON Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,102 Cr | 2.92 | |
| Mar2024 | ₹3,985 Cr | 54.02 | |
| Mar2023 | ₹2,588 Cr | -24.35 | |
| Mar2022 | ₹3,420 Cr | 51.78 | |
| Mar2021 | ₹2,254 Cr | - | |
Compare Capital Work in Progress of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹59,389.8 Cr | -2.6% | -8.7% | -7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -2.6% |
-8.7% |
-7.1% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses